MPWT
IMVT icon

MassMutual Private Wealth & Trust’s Immunovant IMVT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.09K Hold
184
– – ﹤0.01% 1546
2026
Q1 		$4.57K Hold
184
– – ﹤0.01% 1714
2025
Q4 		$4.68K Buy
184
+40
+28% +$892 ﹤0.01% 1699
2025
Q3 		$2.32K Buy
144
+135
+1,500% +$2.19K ﹤0.01% 1942
2025
Q2 		$144 Sell
9
-159
-95% -$2.4K ﹤0.01% 2312
2025
Q1 		$2.87K Buy
+168
New +$3.51K ﹤0.01% 1808
2021
Q2 		– Sell
-26
Closed – – 1251
2021
Q1 		$0 Buy
+26
New +$686 ﹤0.01% 1142

Other funds holding IMVT

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $213M AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MassMutual Private Wealth & Trust's IMVT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Immunovant (IMVT) position steady in Q2 2026 at 184 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

MassMutual Private Wealth & Trust first reported a position in IMVT in Q1 2021 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • MassMutual Private Wealth & Trust held 184 shares of Immunovant worth $7.09K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1546 holding.
  • MassMutual Private Wealth & Trust first reported a position in Immunovant in Q1 2021 and has held it in 7 quarters since.
  • 38 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.